Panion & Bf Biotech Inc. (TPE:1760)

Market Cap	5.00B -16.2%
Revenue (ttm)	2.11B +5.0%
Net Income	214.83M +69.5%
EPS	2.50 +70.1%
Shares Out	85.74M
PE Ratio	23.31
Forward PE	n/a
Dividend	2.00 (3.42%)
Ex-Dividend Date	Jun 11, 2026

Volume	103,759
Open	58.10
Previous Close	58.30
Day's Range	58.00 - 58.50
52-Week Range	57.90 - 76.40
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1760

Financial Performance

In 2025, Panion & Bf Biotech's revenue was 2.06 billion, an increase of 1.66% compared to the previous year's 2.03 billion. Earnings were 190.17 million, an increase of 52.72%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error